Immunoassay Market Detailed In Recent Development To Grow At A Steady Growth Rate By 2024-2031 | Abbott, Beckman Coulter, Inc, F. Hoffmann-La Roche Ltd.

DataM Intelligence has released a new research report on the Immunoassay market. The report provides a detailed analysis of current and emerging trends, offering insights into the market dynamics. It utilizes Porter's Five Forces model to assess key factors such as supplier and customer relationships, risks from various agents, competitive intensity, and opportunities for new entrants. The study also includes research data from various companies, analyzing factors like benefits, gross margins, and strategic decisions in the global market. The report is enriched with tables, charts, and infographics for a clear presentation of the findings.

The global immunoassay market reached US$ 34.6 billion in 2023 and is expected to reach US$ 59.2 billion by 2031, growing at a CAGR of 7.1% during the forecast period 2024-2031.

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/immunoassay-market

The immunoassay market focuses on diagnostic techniques that utilize the immune response to detect and quantify specific substances, such as proteins, hormones, drugs, and pathogens, in biological samples. These assays play a critical role in clinical laboratories, hospitals, and research institutions for disease diagnosis, therapeutic monitoring, and drug development.

List of the Key Players in the Immunoassay Market:

Abbott, Beckman Coulter, Inc, F. Hoffmann-La Roche Ltd, Siemens Healthcare Private Limited, bioMérieux SA, Bio-Rad Laboratories, Inc., DiaSorin S.p.A., BD, Thermo Fisher Scientific Inc., Merck KGaA among others.

Key Developments:

In July 2023, Sysmex Corporation unveiled a novel fully automated and high-speed chemiluminescence immunoassay system at the 2023 AACC exhibition. This innovative system is designed to enhance laboratory efficiency and accuracy in immunoassay testing.

In the same month, SEKISUI Diagnostics introduced the OSOM COVID-19 Antigen Home Test, a lateral flow immunoassay for the diagnosis of the SARS-CoV-2 virus. This home test aims to provide a convenient and accessible solution for COVID-19 screening.

In March 2023, F. Hoffmann-La Roche Ltd. collaborated with Eli Lilly and Company to support the development of Roche's Elecsys Amyloid Plasma Panel (EAPP), which is anticipated to enhance diagnostic capabilities for conditions related to amyloid accumulation.

In February 2023, bioMérieux received 510(k) clearance and the CLIA waiver for their BIOFIRE SPOTFIRE system and BIOFIRE SPOTFIRE respiratory panel, marking a significant advancement in rapid diagnostics for respiratory infections.

Earlier, in February 2022, bioMérieux launched VIDAS KUBE, a next-generation system for automated immunoassay testing. Plans were set for its introduction in selected countries in early 2023, with gradual expansion anticipated in Q2.

In April 2022, Bio-Techne Corporation and Cygnus Technologies, a division of Maravai LifeSciences, launched the Simple Plex HEK 293 HCP 3G assay on the Ella immunoassay platform. This assay is vital for automated process impurity detection in gene and cell therapy applications, focusing on purifying viral particles to minimize host cell protein contamination.

In November 2022, LumiraDx launched a rapid microfluidic immunoassay HbA1c test across Europe, parts of the Middle East, Asia, Latin America, and Africa, enhancing diabetes management through quick and reliable testing.

In February 2022, the NOVEOS Immunoassay Analyzer from Hycor Biomedical Inc. received additional FDA 510(k) clearance. This chemiluminescent immunoassay analyzer is specifically designed to assist in diagnosing allergies by measuring analyte concentrations in human samples.

Research Process:

Both primary and secondary data sources have been used in the global Immunoassay Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Segment Covered in the Immunoassay Market:

By Product Type: Reagents & kits, Analyzers, Software & Services.

By Technology: Radioimmunoassay (RIA), Enzyme Immunoassay (EIA), Fluorescence Immunoassays (FIA), Chemiluminescence Immunoassays (CLIA), Rapid Assays, Others.

By Specimen: Blood, Saliva, Urine, Other Specimen.

By Application: Therapeutic Drug Monitoring, Drug Discovery, Disease Diagnosis.

By End-User: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical and Biotech Companies, Academic Research Centers, Others.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/immunoassay-market

Regional Analysis:

➣ North America (US, Canada, Mexico)

➣ Europe (Germany, Russia, UK, France, Italy, Spain, Rest of Europe)

➣ Asia-Pacific (China, India, Japan, Australia, Rest of Asia Pacific)

➣ South America (Brazil, Argentina, Rest of South America)

➣ Middle East and Africa

**The full version of the report includes an in-depth analysis of emerging players and startups, which will provide valuable insights into the evolving market landscape and key strategies being adopted**

Chapter Outline:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Immunoassay market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Immunoassay Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Immunoassay market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Immunoassay Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Have any Query? Talk to our Expert @ https://www.datamintelligence.com/enquiry/immunoassay-market

The Research Report Offers Answers To The Following Questions:

☛ What is the expected growth rate of the global market for the forecast period?

☛ What are the key driving factors that are responsible to shape the fate of the Immunoassay market during the forecast period?

☛ What will be the overall size of the market during the analysis period?

☛ What are the prominent market trends which influence the development of the Immunoassay market across various regions?

☛ Who are the key market players and the market strategies that have helped them to secure the leading position in the global market?

☛ What are the challenges and threats that are likely to act as a barrier to the growth of the Immunoassay market?

☛ What are the major opportunities that the companies can get to attain success in the world?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.